ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2693

Proof Of Concept: Enthesitis and New Bone Formation In Spondyloarthritis Are Driven By Mechanical Strain and Stromal Cells

Peggy Jacques1, Stijn Lambrecht1, Eveline Verheugen1, Elin Pauwels2, Marleen Verhoye3, Annemie Van der Linden3, George Kollias4, Rik J. Lories5 and Dirk Elewaut6, 1Dept of Rheumatology, Laboratory for Molecular Immunology and Inflammation, Ghent University, Ghent, Belgium, 2Dept of Physics and Astronomy, UGCT, Ghent University, Ghent, Belgium, 3Bio-imaging Lab, University of Antwerp, Antwerp, Belgium, 4Institute of Immunology, Biomedical Sciences Research Center 'Alexander Fleming', Vari, Greece, 5Dept of Development and Regeneration, Laboratory for Skeletal Development and Joint Disorders, KU Leuven, Leuven, Belgium, 6Rheumatology, Department of Rheumatology Ghent University Hospital, Ghent, Belgium

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Enthesitis and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose: Spondyloarthritides (SpA) are characterised by both peripheral and axial arthritis. Hallmarks of peripheral SpA are the development of enthesitis, most typically of the Achilles tendon and plantar fascia, and new bone formation. This study was undertaken to unravel the mechanisms leading towards enthesitis and new bone formation in preclinical models of SpA. TNFΔARE mice are an established model for SpA, characterized by an enhanced TNF messenger RNA stability, which leads to the development of peripheral and axial arthritis (sacroiliitis, spondylitis), and Crohn´s like ileitis.

Methods: To study the development of enthesitis in relation to mechanical strain, hind limb unloading of TNFΔARE mice was performed, followed by histological analysis. Activation of extracellular signal-regulated kinase (Erk1/2) and p38 pathways in response to mechanical strain was studied on Achilles tendon lysates. In addition, TNFΔARE mice were treated with small molecular inhibitors of Erk1/2 and p38. Since new bone formation does not occur in TNFΔARE mice, the collagen antibody-induced arthritis model, which is also characterized by enthesitis, was used to study this particular feature. Hind limb unloading was again performed, followed by histological analysis and micro-CT.

Results: We demonstrated that the first signs of inflammation in TNFΔARE mice were found at the entheses. Importantly, enthesitis occurred equally in the presence or absence of mature T and B cells, underscoring the importance of stromal cells. Hind limb unloading in TNFΔARE mice significantly suppressed inflammation at the synovio-entheseal complex of the Achilles tendon compared to weight bearing controls. Erk1/2 signalling played a crucial role in mechanotransduction associated inflammation. Furthermore, new bone formation was strongly promoted at entheseal sites by biomechanical stress and correlated with the degree of inflammation.

Conclusion: These findings provide a formal proof of the concept that mechanical strain drives both entheseal inflammation and new bone formation in SpA.


Disclosure:

P. Jacques,
None;

S. Lambrecht,
None;

E. Verheugen,
None;

E. Pauwels,
None;

M. Verhoye,
None;

A. Van der Linden,
None;

G. Kollias,
None;

R. J. Lories,

Pfizer Inc,

2,

Celgene,

2,

Abbvie,

5,

Merck Pharmaceuticals,

5,

Janssen Pharmaceutica Product, L.P.,

5;

D. Elewaut,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/proof-of-concept-enthesitis-and-new-bone-formation-in-spondyloarthritis-are-driven-by-mechanical-strain-and-stromal-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology